Magnetic resonance imaging grading of pituitary macroadenoma - SIPAP classification revisited
- PMID: 36969507
- PMCID: PMC10033953
- DOI: 10.1016/j.ejro.2023.100486
Magnetic resonance imaging grading of pituitary macroadenoma - SIPAP classification revisited
Abstract
Background: Magnetic resonance imaging (MRI) is regarded as the modality of choice in diagnosis of pituitary macroadenomas. Since surgery is the first line therapy for all pituitary adenomas, simple and reproducible MRI classification based on major directions of tumour growth is an essential tool. SIPAP MRI classification for pituitary adenoma describes tumor extension in parasellar, suprasellar, infrasellar, anterior and posterior directions. We, therefore, evaluated reproducibility of SIPAP classification in reporting of pituitary adenomas.
Methods: Forty-nine patients with biopsy-proven pituitary macroadenoma were graded according to SIPAP classification. Data was analyzed using Stata version 15. Interobserver variability was calculated using Cohen's Kappa. Comparison between grading before and after treatment was performed by Chi-square test. P values < 0.05 were considered statistically significant.
Results: Individual tumour extensions according to SIPAP for pre- and post-operative grading showed significant difference (p-value <0.001), except for anterior extension. For suprasellar extension, 67.3 % patients had pre-operative grade-3 and 63.3 % had post-operative grade-0. For infrasellar extension, 51.0 % had pre-operative grade-2 and 71.4 % had post-operative grade-0. Anterior, posterior and parasellar extensions showed increased frequency in grade-0 in post-operative stage compared to pre-operative. Substantial inter-observer agreement was achieved for Superior, Inferior, Anterior and Posterior extent with all Kappa statistics values above 0.7 (p-value <0.001).
Conclusion: We propose incorporating simple and objective SIPAP classification in routine MR reporting for ideal pituitary tumour delineation, relationship to juxtasellar structures and tumour size, hence facilitating greater success rate in surgical and subsequent clinical management.
Keywords: Magnetic resonance imaging; Pituitary adenoma; SIPAP classification; Tumor volume.
© 2023 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                References
- 
    - Day P.F., Loto M.G., Glerean M., Picasso M.F., Lovazzano S., Giunta D.H. Incidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a Health Management Organization in Buenos Aires, Argentina. Arch Endocrinol. Metab. 2016;60(6):554–561. doi: 10.1590/2359-3997000000195. - DOI - PMC - PubMed
 
- 
    - Paek S.H., Downes M.B., Bednarz G., Keane W.M., Werner-Wasik M., Curran W.J., Jr, Andrews D.W. Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas. Int. J. Radiat. Oncol. Biol. Phys. 2005;61(3):795–808. doi: 10.1016/j.ijrobp.2004.07.688. - DOI - PubMed
 
LinkOut - more resources
- Full Text Sources
 
        